Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-18-000044)

Filing Details

Accession Number:: 0001213900-18-000044
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-01-02 17:06:53
Reporting Period:: 2017-12-29

Accepted Time:: 2018-01-02 17:06:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1518520	Icagen Inc.	NONE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1353439	Robert Taglich	C/O Icagen, Inc. 4222 Emperor Blvd., Suite 350, Research Triangle Park Durham, NC 27703		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2017-12-29	21,429	$0.37	72,125	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2017-12-29	5,357	$0.02	5,357	$3.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,357	2017-12-29	2019-12-31	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	301,714	Indirect	See footnote

Footnotes

Mr. Taglich indirectly owns an aggregate of 301,714 shares of common stock of Icagen, Inc. as follows: (i) 285,714 shares held in Mr. Taglich's individual retirement account; and (ii) an aggregate of 16,000 shares held by four separate custodial accounts for the benefit of Mr. Taglich's minor children.